-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $80

Benzinga·11/06/2026 13:24:32
Listen to the news
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Eton Pharmaceuticals (NASDAQ:ETON) with a Buy and raises the price target from $70 to $80.